Rene Haas, CEO of Arm Holdings, highlights the impact of a global chip shortage on AI’s potential to cure cancer, noting that advancements in AI could solve complex problems beyond human capability. Despite the challenges, Haas remains optimistic about AI’s future role in cancer research and Arm Holdings’ continued influence in the tech sector.